Literature DB >> 1385705

Inhibition of gastric mucosal laminin receptor by Helicobacter pylori lipopolysaccharide: effect of ebrotidine.

J Piotrowski1, M Morita, A Slomiany, B L Slomiany.   

Abstract

The effect of lipopolysaccharide from H. pylori, a bacteria implicated in the etiology of gastric disease, on the gastric mucosal laminin-receptor interaction was investigated. The receptor protein, prepared from rat gastric epithelial cell membrane by affinity chromatography on laminin-coupled Sepharose, was radioiodinated, and incorporated into liposomes which exhibited specific affinity towards laminin-coated surface. The binding was inhibited by H. pylori lipopolysaccharide, which caused a maximum inhibition of 96% at 50 micrograms/ml. The inhibitory effect of the lipopolysaccharide was prevented by an antiulcer agent, ebrotidine that evoked essentially complete restoration in binding at 6-8 micrograms/ml. The results demonstrate that H. pylori through its lipopolysaccharide interferes with gastric epithelial cell-laminin binding, and that this disruptive effect could be successfully countered by ebrotidine.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1385705

Source DB:  PubMed          Journal:  Biochem Int        ISSN: 0158-5231


  2 in total

Review 1.  Pathogenicity of Helicobacter pylori: a perspective.

Authors:  A Lee; J Fox; S Hazell
Journal:  Infect Immun       Date:  1993-05       Impact factor: 3.441

Review 2.  Ebrotidine.

Authors:  S S Patel; M I Wilde
Journal:  Drugs       Date:  1996-06       Impact factor: 9.546

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.